Close Menu

NEW YORK (GenomeWeb) – Xiamen Spacegen, a provider of oncology molecular diagnostics products and services in China, said today that it has received CE marking for six testing kits.

These kits include a human thyroid carcinoma RET gene fusions detection kit, which is run on a multiplex fluorescence PCR platform; a human MGMT gene methylation detection kit, also run on multiplex fluorescence PCR; and a human EGFR gene T790M mutation detection kit, based on digital PCR technology.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.